NeoVac Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
NeoVac is a clinical-stage biotechnology company focused on a proprietary lipid nanoparticle platform to improve RNA vaccines and medicines for a range of diseases. The approach aims to enhance the delivery of RNA therapies, potentially increasing potency, broadening applications, and reducing adverse effects. By making RNA vaccines more transportable, the platform is intended to support broader global access to improved vaccines. Based at Milton Park in Oxfordshire, NeoVac operates within the biotechnology research sector. Its target customers include researchers and institutions pursuing RNA-based solutions for vaccines and therapies. As a small to mid-sized firm in the clinical-stage space, the company advances its platform through development activities.